Evelyn Partners Investment Management Services Ltd Buys 22,783 Shares of GE HealthCare Technologies Inc. $GEHC

Evelyn Partners Investment Management Services Ltd raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 162.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,768 shares of the company’s stock after buying an additional 22,783 shares during the period. Evelyn Partners Investment Management Services Ltd’s holdings in GE HealthCare Technologies were worth $2,617,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of GEHC. Empowered Funds LLC grew its stake in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter worth $259,000. Cresset Asset Management LLC lifted its holdings in shares of GE HealthCare Technologies by 12.5% in the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after buying an additional 865 shares during the period. Jump Financial LLC grew its position in shares of GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after buying an additional 21,396 shares in the last quarter. Finally, Gamco Investors INC. ET AL increased its stake in shares of GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after buying an additional 320 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.9%

Shares of NASDAQ GEHC opened at $61.12 on Tuesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock has a market capitalization of $27.80 billion, a P/E ratio of 14.62, a price-to-earnings-growth ratio of 1.65 and a beta of 0.72. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The business has a fifty day moving average price of $63.63 and a 200 day moving average price of $70.96.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the business posted $1.01 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini bought 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The shares were bought at an average price of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. Citigroup restated a “neutral” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. HSBC dropped their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Argus reduced their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a report on Tuesday, May 19th. JPMorgan Chase & Co. lowered their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Finally, Jefferies Financial Group dropped their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.